You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 106 No. 2, February 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Oral zinc in macular degeneration

D. A. Newsome, M. Swartz, N. C. Leone, R. C. Elston and E. Miller
LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans 70112.

Macular degeneration associated with age and drusen, an important cause of severe visual loss in older persons, is of unknown cause. The sensory retina and retinal pigment epithelium, which are cell layers in zinc, appear to be prominently involved in the disease process. Because zinc plays a role in the metabolic function of several important enzymes in the chorioretinal complex, we undertook a prospective, randomized, double-masked, placebo-controlled investigation of the effects of oral zinc administration on the visual acuity outcome in 151 subjects with drusen or macular degeneration. Although some eyes in the zinc-treated group lost vision, this group had significantly less visual loss than the placebo group after a follow-up of 12 to 24 months. This is the first controlled oral intervention study to show a positive, if limited, treatment effect in macular degeneration, a major public health problem. Because of the pilot nature of the study and the possible toxic effects and complications of oral zinc administration, widespread use of zinc in macular degeneration is not now warranted.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Modulation of Nrf2-Dependent Antioxidant Functions in the RPE by Zip2, a Zinc Transporter Protein
Rezaei et al.
IOVS 2008;49:1665-1670.
ABSTRACT | FULL TEXT  

Expression of ZnT and ZIP Zinc Transporters in the Human RPE and Their Regulation by Neurotrophic Factors
Leung et al.
IOVS 2008;49:1221-1231.
ABSTRACT | FULL TEXT  

Multivitamin-multimineral supplements and eye disease: age-related macular degeneration and cataract
Seddon
Am. J. Clin. Nutr. 2007;85:304S-307S.
ABSTRACT | FULL TEXT  

The {beta}-Adrenergic Receptor Antagonist Metipranolol Blunts Zinc-Induced Photoreceptor and RPE Apoptosis.
Osborne and Wood
IOVS 2006;47:3178-3186.
ABSTRACT | FULL TEXT  

Increased Glutathione Synthesis through an ARE-Nrf2-Dependent Pathway by Zinc in the RPE: Implication for Protection against Oxidative Stress.
Ha et al.
IOVS 2006;47:2709-2715.
ABSTRACT | FULL TEXT  

Nutritional supplements for macular degeneration
DTB 2006;44:9-11.
ABSTRACT | FULL TEXT  

Doctor, What Vitamins Should I Take for My Eyes?
Mares et al.
Arch Ophthalmol 2004;122:628-635.
FULL TEXT  

The Effect of Five-Year Zinc Supplementation on Serum Zinc, Serum Cholesterol and Hematocrit in Persons Randomly Assigned to Treatment Group in the Age-Related Eye Disease Study: AREDS Report No. 7
The Age-Related Eye Disease Study Research Group
J. Nutr. 2002;132:697-702.
ABSTRACT | FULL TEXT  

AREDS Investigators Distort Findings
Seigel et al.
Arch Ophthalmol 2002;120:100-101.
FULL TEXT  

Molecular genetics of age-related macular degeneration
Stone et al.
Hum Mol Genet 2001;10:2285-2292.
ABSTRACT | FULL TEXT  

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2001;119:1417-1436.
ABSTRACT | FULL TEXT  

Antioxidants, Zinc, and Age-Related Macular Degeneration: Results and Recommendations
Jampol
Arch Ophthalmol 2001;119:1533-1534.
FULL TEXT  

Induction of Heat Shock Protein 72 Protects Retinal Ganglion Cells in a Rat Glaucoma Model
Park et al.
IOVS 2001;42:1522-1530.
ABSTRACT | FULL TEXT  

Zinc and the Eye
Grahn et al.
J. Am. Coll. Nutr. 2001;20:106-118.
ABSTRACT | FULL TEXT  

Depletion of Intracellular Zinc and Copper with TPEN Results in Apoptosis of Cultured Human Retinal Pigment Epithelial Cells
Hyun et al.
IOVS 2001;42:460-465.
ABSTRACT | FULL TEXT  

The Age-Related Eye Disease Study: A Clinical Trial of Zinc and Antioxidants--Age-Related Eye Disease Study Report No. 2
Group
J. Nutr. 2000;130:1516S-1519.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration
Fine et al.
NEJM 2000;342:483-492.
FULL TEXT  

Genetic susceptibility to age related macular degeneration
Yates and Moore
J. Med. Genet. 2000;37:83-87.
ABSTRACT | FULL TEXT  

Correlation Between Age-related Macular Degeneration and Pseudoexfoliation Syndrome in the Population of Crete (Greece)
Kozobolis et al.
Arch Ophthalmol 1999;117:664-669.
ABSTRACT | FULL TEXT  

GABA Receptors of Bipolar Cells From the Skate Retina: Actions of Zinc on GABA-Mediated Membrane Currents
Qian et al.
J. Neurophysiol. 1997;78:2402-2412.
ABSTRACT | FULL TEXT  

ANY QUESTIONS
Bird
BMJ 1996;313:998-998.
FULL TEXT  

Recent Advances: Ophthalmology
Towler and Lightman
BMJ 1996;312:889-892.
ABSTRACT | FULL TEXT  

Diseases of the Retina
D'Amico
NEJM 1994;331:95-106.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.